AI model suggests COVID-19 will grow more infectious

SARS-CoV-2, the virus behind COVID-19, is mutating—and a new AI model suggests many of those mutations could be even more infectious.

When a virus mutates, the researchers explained, it can be benign or even make the virus less dangerous to humans. In this instance, however, many detected mutations have a significant chance of becoming more infectious strains of COVID-19.

Wei’s team has been studying COVID-19 since January, using its machine learning-based model to explore known mutations and more than 3,000 potential future mutations.

“Knowledge about the infectivity of SARS-CoV-2 is a vital factor for preventive measurements against COVID-19 and reopening the global economy,” lead researcher Guowei Wei, a professor at Michigan State University, said in a statement. “A crucial question is what are the ramifications of these mutations to COVID-19 transmission, diagnostics, prevention and treatment.”

The team’s full analysis can be read on the ArXiv preprint server.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.